市场活动

查看全部
    Join BIOCYTOGEN at the PBSS: Toxicological Aspects for Product Quality, Occupational Safety and the Pharmaceuticals

    Join BIOCYTOGEN at the PBSS: Toxicological Aspects for Product Quality, Occupational Safety and the Pharmaceuticals

    September 16, 2025
    Share on:

    We are delighted to announce that Biocytogen will be attending the PBSS: Toxicological Aspects for Product Quality, Occupational Safety and the Pharmaceuticals in the Environment during the Lifecycle of a Drug on September 16th at the Crowne Plaza, CA! Find new connections, explore discoveries in toxicology, therapeutics, and life sciences. Stop by our vendor to meet the team and gain insights of Biocytogen’s achievements in bio-technology and anti-body drug development. We hope to see you there!

    What is the PBSS: Toxicological Aspects for Product Quality, Occupational Safety and the Pharmaceuticals?

    Pharmaceutical & BioScience Society is a non-profit organization of scientists and other professionals in the life sciences that work with biotechnology and pharmaceutical industries. The PBSS(Pharmaceutical & BioScience Society) is a vendor show with a schedule filled with guest speakers, impressive workshops and panel discussions throughout the day. This event is ideal for partnerships, making thoughtful connections with senior scientists, research experts and industry professionals. 

    Event Overview  

    Date: September 16th | Time: 8:30am-5:20pm PST

    Venue: Crowne Plaza Foster City, 1221 Chess Dr, Foster City, CA

    Event Schedule

    For more event information, please refer to PBSS Event Schedule   

    About BIOCYTOGEN

    Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

    We look forward to seeing you in Foster City!